intens
care
medicin
chang
new
type
paper
new
intens
care
understand
diseas
paper
year
later
form
stabl
proport
articl
publish
issu
diversif
receiv
extraordinari
enthusiasm
appreci
worldwid
readership
evidenc
massiv
number
hit
download
first
three
year
review
articl
cover
paper
publish
intens
care
medicin
past
year
focu
cardiac
arrest
ultrasonographi
critic
ill
patient
neurocrit
care
icuacquir
weak
nutrit
acut
kidney
injuri
well
number
miscellan
topic
two
articl
fall
categori
paper
year
later
highlight
two
timeless
cardiovascular
topic
name
vo
relationship
weaninginduc
cardiac
dysfunct
first
articl
vincent
de
backer
apprais
paper
publish
assess
presenc
vo
depend
use
dobutamin
test
articl
author
critic
reevalu
vo
relationship
normal
condit
oxygen
uptak
vo
independ
oxygen
deliveri
extract
rapidli
adapt
chang
howev
vo
becom
depend
acut
circulatori
failur
vo
relationship
thu
major
paramet
guid
therapi
acut
circulatori
failur
bedsid
even
though
applic
past
year
may
view
rather
toosimplist
given
presentday
knowledg
vincent
de
backer
summar
current
understand
vo
relationship
critic
ill
patient
simpl
takehom
messag
first
abnorm
global
vo
depend
exist
stabl
critic
ill
patient
includ
sepsi
acut
respiratori
distress
syndrom
ard
secondli
abnorm
global
vo
depend
exist
sever
case
circulatori
shock
blood
flow
significantli
reduc
may
exist
global
patient
septic
shock
region
patient
sever
sepsi
thirdli
due
microcirculatori
alter
global
determin
vo
unfortun
insuffici
precisesensit
guid
therapi
effect
region
measur
obtain
routin
critic
ill
patient
lastli
studi
timecours
blood
lactat
level
may
repres
surrog
evalu
cellular
oxygen
deficit
second
cardiovascular
review
highlight
teboul
evalu
impact
articl
publish
introduc
concept
weaninginduc
cardiac
dysfunct
sinc
public
latter
articl
weaninginduc
cardiac
dysfunct
realiz
establish
caus
wean
failur
relev
clinic
research
studi
made
major
contribut
toward
improv
diagnosi
concept
evolv
greatli
last
year
presentday
icu
physician
well
awar
wean
failur
may
partial
complet
due
acut
onset
cardiogen
pulmonari
edema
effort
made
accur
diagnos
cardiogen
pulmonari
edema
also
identifi
mechan
respons
develop
wean
ongo
futur
technolog
progress
ultrasonographi
biomark
research
certainli
help
identifi
condit
educ
side
perel
colleagu
contribut
interest
articl
paper
year
later
describ
evolut
concept
respiratori
variat
arteri
pressur
mechan
ventil
cover
period
public
landmark
paper
present
day
comprehens
review
may
help
reader
understand
physiolog
phenomenon
specif
term
clinic
applic
limit
ddown
delta
decreas
systol
blood
pressur
sbp
dup
delta
increas
sbp
two
main
compon
respiratori
variat
arteri
pressur
author
also
note
decis
regard
hemodynam
manag
base
integr
paramet
variou
sourc
singl
paramet
take
consider
entir
clinic
physiolog
pictur
new
intens
care
paper
dalabih
colleagu
discuss
manag
acut
right
ventricular
decompens
chronic
pulmonari
hypertens
reader
remind
reduc
limit
right
ventricular
afterload
key
good
clinic
manag
regardless
etiolog
paper
includ
welldesign
figur
summar
challeng
recommend
good
clinic
manag
entiti
includ
concern
mechan
ventil
strategi
entir
period
record
human
histori
world
never
global
age
today
therefor
surpris
proport
elderli
patient
admit
icu
increas
even
circulatori
shock
use
icu
admiss
age
popul
hot
topic
worldwid
mortal
rate
known
increas
age
impact
age
outcom
circulatori
shock
well
defin
biston
et
al
explor
topic
perform
secondari
analysi
data
larg
random
trial
compar
effect
dopamin
norepinephrin
outcom
icu
mortal
rate
higher
elderli
year
elderli
year
patient
day
hospit
discharg
month
followup
elderli
patient
dead
month
mortal
rate
increas
age
type
shock
use
multivari
analysi
risk
death
higher
elderli
patient
compar
patient
age
year
analysi
age
independ
associ
higher
mortal
rate
patient
circulatori
failur
whatev
etiolog
year
admiss
patient
age
year
die
assess
central
venoustoarteri
carbon
dioxid
differ
p
va
co
seem
help
assess
adequaci
cardiac
index
ci
oxygen
demand
increment
dose
dobutamin
infus
patient
stabl
chronic
heart
failur
whether
phenomena
observ
stabl
septic
shock
patient
present
known
moreov
demonstr
p
va
co
substitut
central
venoustoarteri
co
differ
dpco
critic
ill
patient
mallat
al
tri
solv
conundrum
assess
behavior
dpco
index
co
product
vco
ci
ratio
hemodynam
stabl
septic
shock
patient
ongo
sign
tissu
hypoperfus
given
increment
dose
dobutamin
twentytwo
hemodynam
stabl
septic
shock
patient
sign
global
tissu
hypoxia
normal
blood
lactat
level
enrol
prospect
studi
despit
doserel
increas
ci
dobutamin
infus
result
dosedepend
decreas
dpco
vo
vco
show
statist
signific
increas
parallel
increas
dose
dobutamin
author
conclud
measur
dpco
may
use
tool
assess
adequaci
oxygen
suppli
metabol
oxygen
demand
schmidt
al
retrospect
evalu
impact
fluid
balanc
fb
mortal
cohort
adult
patient
treat
extracorpor
membran
oxygen
ecmo
refractori
heart
failur
patient
treat
ecmo
refractori
respiratori
failur
earli
posit
fb
especi
day
found
robust
independ
predictor
mortal
regardless
primari
diagnosi
acut
kidney
injuri
aki
renal
replac
therapi
rrt
use
addit
author
confirm
aki
ecmo
frequent
patient
requir
continu
rrt
greater
risk
mortal
conclus
drawn
author
prospect
studi
tight
fb
control
first
day
ecmo
warrant
hypothermia
remain
hot
topic
cardiac
arrest
ca
manag
profil
public
debati
et
al
report
random
multicent
studi
impact
intraarrest
therapeut
hypothermia
iath
outofhospit
cardiac
arrest
ohca
patient
control
group
patient
cool
perform
usual
ie
soon
possibl
hospit
admiss
wherea
intervent
group
patient
patient
receiv
infus
cold
salin
extern
cool
cardiopulmonari
resuscit
cpr
patient
includ
studi
whatev
initi
rhythm
even
though
larg
proport
patient
nonshock
rhythm
iath
signific
effect
laboratori
marker
inflamm
brain
damag
neuronspecif
enolas
h
outcom
even
though
target
temperatur
achiev
earlier
intervent
group
side
effect
iath
report
sever
neurolog
impair
secondari
hypoxicischem
brain
injuri
common
resuscit
ca
earli
identif
patient
chanc
good
neurolog
outcom
help
avoid
inappropri
treatment
prognost
never
straightforward
complic
use
mild
therapeut
hypothermia
recent
advisori
statement
european
resuscit
council
european
societi
intens
care
medicin
esicm
provid
evidencebas
expert
consensu
guidanc
prognost
comatos
survivor
ca
follow
gradebas
systemat
review
expert
consensu
achiev
use
webbas
delphi
methodolog
qualiti
evid
low
low
almost
studi
review
care
clinic
neurolog
examin
adequ
time
allow
exclud
confound
factor
remain
foundat
prognost
comatos
patient
ca
robust
predictor
poor
prognosi
coma
patient
absent
extensor
postur
h
ca
whether
treat
mth
bilater
absenc
pupillari
corneal
reflex
bilater
absenc
wave
somatosensori
evok
potenti
less
robust
predictor
includ
statu
myoclonu
elev
neuronspecif
enolas
nse
h
nonreact
electroencephalographi
eeg
pattern
rewarm
neuroimag
evid
diffus
postanox
injuri
prognost
use
multipl
variabl
prefer
often
limit
shortag
relev
investig
expertis
result
prognost
test
produc
conflict
result
prognost
remain
uncertain
clinic
observ
reevalu
recommend
variou
biomark
also
use
assess
sever
hypox
brain
injuri
allow
prognost
ca
optim
biomark
cutoff
valu
uncertain
predict
abil
presenc
mth
uncertain
neuropeptid
secretoneurin
sn
specif
express
neuron
tissu
multipl
biolog
function
upregul
hypoxia
therefor
potenti
novel
biomark
hypox
brain
injuri
ca
prognost
valu
sn
recent
investig
prospect
observ
studi
patient
admit
icu
success
cpr
follow
ca
averag
sixfold
increas
serum
sn
level
within
first
h
cpr
significantli
higher
level
patient
poor
neurolog
outcom
compar
good
neurolog
outcom
sn
predict
outcom
earlier
nse
like
influenc
mth
therefor
potenti
superior
biomark
earli
neurolog
prognost
ca
explor
larg
dataset
could
help
improv
understand
efficaci
variou
clinic
intervent
bougouin
et
al
report
interest
result
larg
populationbas
registri
sudden
cardiac
death
greater
pari
area
home
gener
french
popul
case
ohca
includ
registri
period
relat
extracardiac
etiolog
cardiac
origin
patient
ultim
admit
hospit
aliv
initi
rhythm
shockabl
case
underw
coronari
angiographi
almost
proport
treat
therapeut
hypothermia
studi
demonstr
prognosi
clearli
remain
poor
sinc
patient
ohca
cardiac
origin
patient
actual
underw
attempt
resuscit
patient
admit
aliv
discharg
aliv
factor
associ
prognosi
bystand
cpr
initi
shockabl
rhythm
increas
surviv
age
longer
respons
time
occurr
cardiac
arrest
home
epinephrin
dose
mg
resuscit
decreas
surviv
alalwan
et
al
report
incid
prognosi
cpr
among
patient
alreadi
mechan
ventil
use
patient
data
finnish
medicar
databas
januari
decemb
among
patient
receiv
inhospit
cpr
period
surviv
cpr
perform
patient
alreadi
ventil
surviv
hospit
discharg
compar
patient
alreadi
ventil
followup
surviv
patient
cpr
ventil
icu
staff
famili
member
discuss
manag
patient
awar
result
howev
interpret
caution
light
paper
discuss
next
efendjev
et
al
report
tempor
trend
ca
incid
outcom
finnish
icu
use
patient
data
larg
nationwid
icu
databas
therapeut
intervent
score
system
document
patient
need
cpr
admit
icu
reason
cardiac
arrest
icuca
patient
enrol
studi
crude
incid
icuca
admiss
decreas
time
icuca
occur
nonop
cardiovascular
patient
vast
major
occur
first
day
icu
patient
ventil
inhospit
mortal
decreas
studi
period
potenti
benefit
pointofcar
ultrasound
us
fair
expect
util
icu
sometim
need
reconsid
given
gener
pauciti
literatur
topic
mainli
due
rel
novelti
mani
applic
us
three
articl
publish
intens
care
medicin
last
year
open
interest
procon
debat
use
echographi
initi
manag
critic
ill
patient
import
aspect
clinic
applic
new
technolog
develop
train
bedsid
statement
publish
intens
care
medicin
group
expert
publish
result
round
tabl
held
pari
esicm
congress
intern
statement
report
detail
train
standard
advanc
critic
care
echocardiographi
form
basi
futur
european
certif
advanc
critic
care
echocardiographi
prospect
singlecent
studi
nguyen
et
al
determin
learn
curv
intensivist
perform
usguid
jugular
central
venou
cathet
placement
train
program
includ
min
instruct
illustr
procedur
manipul
probe
learn
curv
evalu
use
two
score
system
first
evalu
prepar
steril
cover
manipul
probe
second
evalu
technic
skill
vessel
identif
needl
visual
intern
jugular
punctur
guid
insert
among
other
author
also
record
time
requir
procedur
find
demonstr
requir
skill
easili
acquir
averag
six
eight
procedur
total
time
need
cathet
placement
arriv
us
machin
patient
room
dress
min
eight
procedur
volpicelli
et
al
perform
singlecent
prospect
studi
determin
abil
lung
ultrasonographi
lu
approxim
quantifi
pneumothorax
volum
use
project
lung
point
chest
result
compar
measur
made
use
comput
tomographi
ct
scan
patient
andor
chest
xray
patient
train
oper
perform
lu
total
spontan
breath
patient
previous
diagnos
pneumothorax
consecut
enrol
studi
author
report
project
lung
point
chest
appear
use
predictor
pneumothorax
volum
lu
reliabl
classifi
pneumothorax
small
larg
follow
public
paper
howev
interest
item
correspond
publish
intens
care
medicin
shed
light
potenti
limit
approach
singlecent
prospect
studi
begot
et
al
assess
abil
resid
novic
lu
identifi
quantifi
unlocul
pleural
effus
limit
train
program
h
instruct
min
illustr
case
min
tutor
handson
focu
identif
quantif
pleural
effus
compar
abil
intensivist
experienc
field
quantif
base
maxim
interpleur
distanc
twelv
resid
examin
patient
suspect
pleural
effus
lead
mean
evalu
per
resid
agreement
resid
novic
experienc
intensivist
consid
good
excel
diagnosi
lung
agreement
also
excel
interpleur
space
measur
final
base
result
singlecent
prospect
studi
blunt
trauma
patient
leblanc
et
al
report
extent
lung
contus
quantifi
train
oper
use
predefin
lu
score
good
predictor
occurr
ard
use
berlin
definit
follow
day
extent
lung
contus
lu
also
well
correl
ct
scan
measur
addit
author
confirm
perform
lu
diagnosi
injuri
context
pneumothorax
hemothorax
pathophysiolog
manag
sever
acut
neurolog
disord
review
intens
care
medicin
macdonald
et
al
recent
review
pathophysiolog
aneurysm
subarachnoid
hemorrhag
sah
review
appear
understand
diseas
seri
highlight
earli
brain
injuri
impact
mortal
injuri
relat
immedi
effect
aneurysm
ruptur
subsequ
cellular
metabol
inflammatori
consequ
result
impair
neurovascular
coupl
disrupt
bloodbrain
barrier
cerebr
ischemia
cerebr
edema
new
insight
pathogenesi
delay
cerebr
ischemia
import
earli
identif
effect
treatment
minim
poor
outcom
discuss
import
sahrel
system
inflammatori
respons
cardiovascular
respiratori
complic
also
highlight
increas
number
patient
acut
ischem
stroke
ai
admit
icu
aggress
physiolog
optim
manag
poststrok
complic
includ
relat
thrombolyt
therapi
well
patient
receiv
recent
releas
treatment
although
detail
european
us
guidanc
manag
ai
littl
focus
icu
manag
recent
structur
narr
review
provid
key
recommend
critic
care
manag
ai
addit
four
intervent
support
class
evid
care
multidisciplinari
team
stroke
unit
intraven
tissu
plasminogen
activ
within
h
thrombot
stroke
onset
aspirin
within
h
stroke
onset
decompress
craniectomi
malign
middl
cerebr
arteri
infarct
author
provid
recommend
base
best
avail
evid
airway
ventil
manag
hemodynam
fluid
optim
fever
glycem
control
manag
anticoagul
antiplatelet
thromboprophylaxi
therapi
control
seizur
statu
epilept
se
second
common
lifethreaten
neurolog
emerg
ai
carri
high
risk
mortal
morbid
articl
entitl
new
statu
epilepticu
rossetti
bleck
review
contemporari
manag
novel
therapi
se
crucial
import
rapid
seizur
control
emphas
author
recommend
three
sequentialand
escalatinglin
treatment
discuss
detail
role
newer
thirdlin
therapi
ketamin
debat
determin
line
life
death
whether
diagnos
cardiorespiratori
neurolog
criteria
crucial
inde
death
pronounc
treatment
inappropri
also
societi
requir
confirm
event
certainti
advanc
medicin
technolog
made
possibl
support
replac
fail
organ
mani
circumst
challeng
commonli
held
notion
biolog
death
die
process
although
year
past
sinc
concept
brain
death
introduc
clinic
practic
mani
controversi
surround
settl
particularli
regard
inevit
associ
brain
death
organ
donat
truog
miller
debat
issu
within
context
organ
donat
dead
donor
rule
argu
brain
death
coher
biolog
scientif
understand
death
although
intuit
plausibl
scientif
support
patient
irrevers
comatos
apneic
dead
increas
call
intern
standard
determin
death
diagnos
cardiorespiratori
neurolog
criteria
agreement
precis
terminolog
improv
clariti
discuss
debat
death
recent
report
summar
first
phase
develop
intern
standard
singl
oper
definit
death
base
clear
biomed
standardsrath
anatom
base
term
cardiac
brain
deathha
propos
work
parti
recommend
death
defin
perman
loss
capac
conscious
brain
stem
function
consequ
perman
cessat
circul
catastroph
brain
injuri
recommend
fulfil
requir
determin
death
use
clinic
criteria
base
direct
observ
examin
patient
specifi
precondit
fulfil
reinforc
exclus
confound
factor
next
phase
work
includ
broader
represent
intern
stakehold
develop
clinic
practic
guidelin
determin
death
patient
admit
icu
manag
acut
neurolog
insult
traumat
hemorrhag
ischem
brain
injuri
wherea
mani
other
develop
brain
dysfunct
consequ
underli
critic
ill
monitor
brain
neurolog
function
therefor
major
relev
critic
care
set
fundament
neurolog
monitor
serial
clinic
assess
neurolog
statu
pragmat
approach
neurolog
examin
critic
ill
patient
recent
publish
expert
panel
esicm
consensu
statement
highlight
import
conduct
full
clinic
neurolog
examin
icu
patient
stress
includ
assess
conscious
cognit
examin
brain
stem
motor
function
daili
sedat
hold
allow
assess
neurolog
function
recommend
patient
except
reduc
intracrani
complianc
guidanc
highlight
import
glasgow
coma
score
gc
standard
intern
recogn
method
evalu
patient
global
neurolog
statu
associ
identif
document
local
sign
pupil
respons
limb
weak
gc
remain
mainstay
clinic
assess
year
sinc
first
descript
main
limit
gc
verbal
respons
assess
intub
patient
brainstem
function
directli
consid
guidanc
recommend
four
score
design
valid
overcom
issu
use
differenti
yet
patient
gc
although
limit
evid
approach
greater
interrat
reliabl
prognost
valu
gc
alon
clinic
assess
limit
sedat
patient
decreas
consciou
level
variou
devic
avail
neurolog
monitor
circumst
techniqu
provid
global
region
monitor
cerebr
perfus
oxygen
metabol
statu
use
braininjur
patient
provid
earli
warn
impend
cerebr
hypoxiaischemia
metabol
distress
neurocrit
care
societi
esicm
publish
comprehens
consensusbas
expert
guidanc
multimod
neuromonitor
systemat
literatur
review
specif
physiolog
process
relev
manag
critic
ill
neurolog
patient
undertaken
use
formul
recommend
individu
monitor
techniqu
multimod
monitor
valu
monitor
output
brain
physiolog
interpret
skill
clinician
use
direct
individu
therapeut
option
mani
neuromonitor
invas
avail
specialist
neurocrit
care
unit
interest
develop
noninvas
techniqu
use
wide
grow
noninvas
assess
intracrani
pressur
icp
one
techniqu
sekhon
et
al
investig
relationship
measur
optic
nerv
sheath
diamet
onsd
ct
directli
measur
icp
retrospect
cohort
studi
patient
sever
traumat
brain
injuri
tbi
onsd
highli
discriminatori
predict
intracrani
hypertens
icp
c
vs
mmhg
power
predict
increas
icp
ct
find
valu
eeg
diagnosi
manag
clinic
nonconvuls
seizur
ncsz
patient
primari
neurolog
condit
well
establish
clear
critic
ill
patient
risk
develop
ncsz
retrospect
studi
kurtz
et
al
review
surgic
icu
patient
without
primari
neurolog
diseas
underw
continu
eeg
monitor
alter
mental
state
ncsz
identifi
patient
period
epileptiform
discharg
onethird
patient
ncsz
nonconvuls
statu
epilepticu
ncse
case
septic
ncsz
independ
associ
poor
outcom
clearli
urgent
need
larg
prospect
studi
determin
exact
preval
clinic
impact
ncsz
critic
care
also
investig
whether
treatment
improv
outcom
meantim
recommend
eeg
monitor
undertaken
exclud
ncsz
ncse
patient
unexplain
persist
alter
conscious
critic
ill
polyneuropathi
myopathi
cipnm
neuromuscular
disord
develop
admiss
icu
result
icuacquir
weak
icuaw
advers
effect
shortand
longterm
outcom
includ
delay
wean
mechan
ventil
increas
icu
hospit
length
stay
increas
mortal
longterm
disabl
mechan
icuaw
multipl
yet
fulli
elucid
disturb
balanc
myosin
heavi
chain
myhc
implic
pathogenesi
myopathi
investig
hypothesi
wollersheim
et
al
measur
myhc
synthesi
degrad
skelet
muscl
critic
ill
patient
high
risk
develop
icuaw
open
biopsi
vastu
laterali
muscl
analysi
mrna
protein
content
cellular
ultrastructur
electron
microscopi
perform
median
time
day
icu
admiss
second
biopsi
perform
patient
still
icu
median
time
day
admiss
timedepend
chang
myofib
architectur
myhc
synthesi
degrad
correl
medic
research
council
mrc
rate
muscl
strength
control
biopsi
obtain
agedmatch
healthi
patient
undergo
elect
hip
replac
surgeri
icuacquir
muscl
wast
character
earli
day
disrupt
myofib
ultrastructur
later
day
atrophi
slowand
fasttwitch
myofib
decreas
compar
control
myhc
mrna
protein
express
present
day
persist
day
studi
support
hypothesi
decreas
synthesi
increas
degrad
myhc
contribut
icuaw
suggest
pathogenesi
initi
earli
onset
critic
ill
although
often
suspect
clinic
definit
diagnosi
icuaw
reli
structur
clinic
evalu
demonstr
decreas
muscl
strength
assess
use
mrc
scale
nerv
conduct
studi
nc
needl
electromyographi
emg
manual
test
muscl
strength
requir
awak
cooper
patient
comprehens
electrophysiolog
examin
timeconsum
physic
uncomfort
awak
patient
moss
colleagu
demonstr
simplifi
approach
electrophysiolog
assess
cipnm
use
combin
unilater
peron
motor
sural
sensori
nc
sensit
high
specif
diagnosi
cipnm
find
suggest
patient
normal
peron
sural
nc
unlik
cipnm
test
emg
unlik
alter
conclus
howev
nc
abnorm
diagnosi
cipnm
explor
comprehens
electrophysiolog
investig
streamlin
approach
diagnosi
cipnm
may
facilit
routin
diagnost
test
monitor
weak
critic
ill
patient
lactat
previous
consid
harm
wast
product
cerebr
anaerob
metabol
glucos
known
possibl
benefici
effect
brain
increas
lactat
tbi
may
consequ
increas
cerebr
glycolysi
rather
hypoxiaischemia
lactat
shuttl
lactateproduc
cell
astrocyt
lactateconsum
cell
neuron
adapt
respons
limit
substrat
reduct
maxim
energi
product
also
experiment
evid
lactat
neuroprotect
acut
brain
injuri
recent
prospect
studi
multimod
brain
monitor
use
investig
metabol
hemodynam
effect
exogen
administr
hyperton
sodium
lactat
patient
sever
tbi
lactat
administr
result
statist
signific
increas
cerebr
microdialysismonitor
concentr
lactat
pyruv
glucos
concomit
reduct
glutam
icp
taken
togeth
data
suggest
exogen
lactat
util
preferenti
effici
energi
sourc
injur
human
brain
result
spare
cerebr
glucos
singer
et
al
express
vision
regard
nutrit
new
intens
care
articl
author
point
increas
bodi
evid
demonstr
benefit
earli
enter
feed
rais
concern
regard
overfeed
use
predict
equat
target
nutrit
requir
hickmann
et
al
explor
chang
rest
energi
expenditur
ree
sepsi
exercis
describ
poor
accuraci
frequent
use
predict
equat
well
demonstr
strong
correl
measur
ree
creactiv
protein
level
thu
studi
ree
increas
presenc
activ
exercis
present
passiv
exercis
associ
increas
ree
find
help
sinc
passiv
exercis
often
use
activ
exercis
prevent
muscl
loss
critic
ill
patient
regard
specif
nutrient
singer
et
al
recommend
glutamin
administ
intraven
iv
glutamin
patient
requir
parenter
nutrit
except
suffer
organ
failur
involv
liver
kidney
also
suggest
supplement
fatti
acid
gday
fatti
acid
continu
administ
enter
patient
suffer
ard
associ
improv
pao
fio
ratio
ratio
arteri
oxygen
partial
pressur
fraction
inspir
oxygen
decreas
length
ventil
nevertheless
administ
larger
dose
bolu
result
confirm
perezbarcena
et
al
studi
effect
iv
glutamin
trauma
popul
author
find
clinic
advantag
treatment
possibl
relat
fact
dose
administ
increas
plasma
level
normal
valu
treat
group
start
low
plasma
level
baselin
studi
reinforc
hypothesi
administr
specif
nutrient
guid
adequ
level
ensur
clinic
efficaci
ident
conclus
reach
nie
et
al
regard
administr
eicosapentaeno
acid
epa
gammalinolen
acid
gla
critic
ill
patient
suffer
ard
metaanalysi
mix
studi
continuousbolu
enter
administr
variou
dose
mainli
epa
also
dha
andor
gla
show
advantag
term
mortal
length
ventil
icu
stay
howev
improv
pao
fio
ratio
day
found
suggest
pharmacolog
effect
continu
enter
administr
appear
superior
highdos
bolu
administr
studi
tight
glucos
control
patient
fail
reproduc
larg
scale
hyperglycemia
remain
concern
dean
et
al
observ
acut
hyperglycemia
critic
ill
patient
found
risk
death
increas
increas
acut
glycemia
mmoll
patient
diabet
glycat
hemoglobin
admiss
associ
lost
diabet
patient
poorli
control
find
help
understand
discrep
current
literatur
daviaud
et
al
studi
patient
undergo
ohca
resuscit
admit
larg
ca
center
franc
patient
rel
higher
level
blood
glucos
level
admiss
wors
outcom
increas
median
blood
glucos
level
first
h
found
independ
predictor
poor
outcom
odd
ratio
confid
interv
ci
p
author
suggest
test
strategi
combin
control
glycemia
minim
glucos
variabl
improv
postresuscit
care
final
routin
measur
gastric
residu
volum
recent
challeng
hamada
et
al
discuss
innov
way
measur
gastric
residu
volum
use
ultrasonographi
show
accur
compar
ct
volumetr
assess
gastric
content
author
found
good
correl
mani
case
suggest
techniqu
could
easili
use
bedsid
assess
patient
risk
larg
gastric
residu
aspir
well
evalu
enter
nutrit
toler
krag
et
al
attempt
find
evid
stress
ulcer
prophylaxi
use
h
blocker
trial
protonpump
inhibitor
ppi
two
studi
mostli
intraven
trial
includ
although
differ
icu
mortal
observ
signific
decreas
gastrointestin
bleed
compar
control
howev
find
could
confirm
analysi
trial
adequ
random
sequenc
gener
alloc
conceal
blind
n
rais
question
qualiti
studi
differ
nosocomi
pneumonia
observ
interestingli
enter
feed
alon
associ
increas
incid
ventilatorassoci
pneumonia
suggest
enter
feed
may
suffici
prevent
upper
gastrointestin
bleed
year
develop
public
wide
accept
kidney
diseas
improv
global
outcom
kdigo
clinic
practic
guidelin
aki
result
standard
diagnosi
stage
aki
howev
valid
classif
still
miss
pediatr
popul
appli
kdigo
criteria
patient
univers
michigan
pediatr
critic
care
databas
selewski
cowork
demonstr
incid
aki
major
patient
reach
aki
stage
current
among
largest
pediatr
cohort
investig
syndrom
patient
cohort
compris
newborn
children
age
year
alreadi
demonstr
adult
patient
author
found
aki
stage
pediatr
patient
significantli
associ
increas
length
stay
requir
mechan
ventil
mortal
ci
sepsi
known
major
caus
aki
critic
ill
patient
recent
research
provid
new
insight
poorli
understood
pathophysiolog
entiti
would
appear
reduc
renal
blood
flow
renal
ischemia
major
compon
reduc
glomerular
filtrat
rate
gfr
sepsi
renal
inflammatori
immunolog
mechan
appear
result
tubular
cell
injuri
like
mediat
damag
pathogenassoci
molecular
pattern
pathogenassoci
molecular
pattern
molecul
pamp
damagedangerassoci
molecular
pattern
molecul
damp
filter
glomerulum
recogn
renal
tubular
cell
via
sever
receptor
tolllik
receptor
result
overexpress
nfkb
subsequ
releas
tumor
necrosi
factor
cytokin
lead
reduc
sodium
reabsorpt
activ
tubloglomerular
feedback
tubular
cell
injuri
eventu
factor
contribut
loss
gfr
septic
aki
furthermor
retrospect
analysi
larg
intern
multicent
databas
includ
patient
septic
shock
found
develop
aki
occur
roughli
patient
depend
causal
pathogen
although
pulmonari
infect
far
lead
caus
septic
shock
multivari
analysi
fulli
adjust
age
comorbid
sever
diseas
show
major
risk
factor
appear
site
infect
urinari
tract
infect
carri
highest
risk
aki
ci
follow
gastrointestin
blood
stream
infect
averag
prevent
aki
sepsi
nonsepsisassoci
critic
ill
primarili
depend
avoid
addit
harm
kidney
previous
underestim
risk
factor
may
type
fluid
use
volum
resuscit
recent
larg
random
trial
fluid
resuscit
patient
sepsi
well
critic
ill
patient
reveal
hydroxethylstarch
he
carri
signific
risk
aki
well
requir
rrt
even
appear
sign
increas
mortal
initi
led
european
medicin
agenc
ema
recommend
suspens
licens
he
indic
recommend
subsequ
partli
withdrawn
allow
use
starch
sever
hemorrhag
trauma
surgeri
discret
treat
physician
decis
question
depth
six
expert
ema
commentari
publish
new
intens
care
stress
continu
use
he
mean
expos
larg
number
patient
signific
risk
potenti
detriment
consequ
commentari
support
systemat
review
investig
tissu
deposit
he
extract
data
human
total
patient
anim
studi
author
demonstr
signific
accumul
he
sever
tissu
predominantli
kidney
also
relev
amount
liver
bone
marrow
skin
addit
site
he
deposit
lymph
node
spleen
lung
pancrea
intestin
muscl
trophoblast
placent
stroma
interestingli
report
sometim
longlast
pruritu
mainli
origin
studi
he
appli
hemodilut
treatment
acut
hear
loss
he
uptak
kidney
could
observ
earli
min
infus
storag
organ
cumul
increas
increas
amount
he
administ
case
he
accumul
longlast
persist
year
skin
kidney
respect
remark
patient
he
storag
associ
symptom
occur
alreadi
low
dose
gkg
bodi
weight
accompani
editori
howev
address
issu
benefit
versu
harm
extrem
valid
manner
colloid
least
theoret
enabl
faster
effect
intravascular
volum
expans
colloid
less
risk
volum
overload
long
glycocalix
significantli
damag
thu
earli
volum
resuscit
hemodynam
instabl
suffici
treatabl
crystalloid
colloid
may
altern
stabil
patient
issu
crystalloid
administr
also
requir
intens
scrutini
light
recent
experiment
find
frequent
use
crystalloid
fluid
sodium
chlorid
solut
normal
salin
solut
far
physiolog
high
chlorid
content
mmoll
found
induc
metabol
acidosi
vasoconstrict
kidney
reduc
gfr
healthi
volunt
recent
observ
beforeaft
studi
show
switch
normal
salin
balanc
solut
chlorid
content
mmoll
result
less
aki
fewer
requir
rrt
aspect
investig
retrospect
analysi
nearli
patient
system
inflammatori
respons
syndrom
sir
treat
crystalloid
author
studi
look
mortal
associ
chlorid
administr
quantifi
millimolar
chlorid
per
liter
volum
administr
found
patient
receiv
mmol
chlorid
significantli
increas
mortal
compar
receiv
mmol
chlorid
vs
respect
howev
effect
also
depend
total
volum
administ
neg
effect
chlorid
could
shown
patient
receiv
ml
fluid
period
multivari
analysi
adjust
fluid
volum
sever
diseas
character
acut
physiolog
score
show
increas
risk
mortal
ci
increas
volum
adjust
chlorid
load
mmoll
accompani
editori
howev
highlight
although
studi
provid
signal
possibl
harm
normal
salin
treat
physician
consid
effect
appear
dose
depend
random
control
trial
prove
assumpt
although
still
absent
ongo
result
expect
soon
result
avail
physician
continu
use
normal
salin
may
reassur
year
clinic
experi
use
fact
icu
patient
receiv
salin
random
control
trial
issu
volum
overload
also
investig
specif
cohort
patient
requir
ecmo
either
refractori
heart
failur
n
refractori
respiratori
failur
n
also
treat
rrt
posit
fluid
balanc
day
ecmo
treatment
turn
import
predictor
mortal
vulner
cohort
futur
intervent
studi
aim
limit
posit
fluid
balanc
show
whether
modifi
risk
factor
realli
improv
outcom
renal
recoveri
aki
recent
emerg
issu
signific
implic
healthcar
system
avail
data
indic
critic
patient
requir
rrt
surviv
discharg
may
remain
chronic
dialysi
although
largest
random
trial
rrt
show
renal
recoveri
rate
day
howev
even
patient
experienc
aki
never
requir
rrt
show
recoveri
may
develop
chronic
kidney
diseas
later
potenti
end
dialysi
year
discharg
hospit
popul
current
remain
larg
undetect
major
problem
may
use
estim
gfr
egfr
mainli
base
serum
creatinin
level
egfr
appear
overestim
renal
function
patient
stay
icu
longer
time
overestim
nice
demonstr
secondari
analysi
epan
trial
involv
patient
show
reduct
creatinin
product
posit
correl
length
stay
icu
like
due
muscl
loss
popul
discrep
measur
creatinin
clearanc
egfr
becam
appar
patient
stay
icu
day
pronounc
aki
also
appar
group
experi
aki
result
clearli
indic
without
perform
proper
creatinin
clearanc
test
patient
reduc
renal
function
miss
probabl
follow
renal
function
hyponatremia
defin
serum
sodium
concentr
mmoll
present
emerg
admiss
hospit
occur
critic
ill
patient
symptomatolog
may
vari
subtl
life
threaten
despit
manag
patient
remain
problemat
background
esicm
european
societi
endocrinolog
ese
european
renal
associationeuropean
dialysi
transplant
associ
eraedta
repres
new
guidanc
bodi
european
renal
best
practic
erbp
develop
clinic
practic
guidelin
diagnost
approach
treatment
hyponatremia
joint
ventur
three
societi
repres
specialist
natur
interest
hyponatremia
major
focu
place
treatment
acut
hyponatremia
lifethreaten
condit
character
coma
seizur
vomit
sever
cardiorespiratori
stress
requir
urgent
therapi
administr
hyperton
salin
final
way
intens
care
medicin
practic
heavili
influenc
work
circumst
critic
care
specialist
even
region
icu
found
joynt
tat
present
quick
overview
import
ten
diseas
critic
care
specialist
know
practic
hong
kong
cours
sever
acut
respiratori
syndrom
sar
top
list
effect
tradit
chines
medicin
toxic
underestim
taccon
et
al
publish
new
intens
care
paper
fever
control
icu
remind
reader
high
preval
elev
bodi
temperatur
critic
ill
patient
review
discuss
question
whether
fever
actual
treat
one
hand
patient
infect
relationship
earli
fever
decreas
mortal
suggest
potenti
protect
effect
fever
hand
effect
seem
persist
high
temperatur
condit
acut
lung
injuri
fever
appear
deleteri
howev
evidencebas
medic
data
treat
fever
current
lack
result
even
contradictori
studi
expect
heat
studi
critic
ill
patient
known
suspect
infect
face
ii
studi
unselect
critic
ill
patient
fever
cass
studi
septic
shock
patient
evalu
clinic
result
practic
icu
import
larg
observ
cohort
studi
galland
et
al
evalu
determin
longand
shortterm
surviv
critic
ill
total
initi
icu
admiss
analyz
show
mortal
rate
within
day
respect
author
observ
two
phase
surviv
relat
critic
ill
shortterm
mortal
mainli
determin
acut
ill
effect
decay
rel
rapidli
mortal
beyond
month
among
surviv
point
mainli
determin
age
comorbid
recognit
find
relev
discuss
patient
surrog
achiev
goal
care
retrospect
cohort
studi
gantner
et
al
report
afterhour
discharg
remain
import
independ
predictor
hospit
mortal
readmiss
icu
author
use
australian
new
zealand
intens
care
societi
adult
patient
databas
anzic
apd
patient
admit
australian
new
zealand
icu
januari
decemb
among
patient
analyz
discharg
hour
patient
higher
mortal
other
vs
respect
interest
editori
guidet
bion
entitl
night
thought
accompani
paper
ghassemi
et
al
massachusett
institut
technolog
propos
origin
approach
optim
unfraction
heparin
ufh
dose
emphas
activ
partial
thromboplastin
time
aptt
h
ufh
infus
frequent
subor
supratherapeut
rang
base
usual
guidelin
use
multiparamet
intellig
monitor
intens
care
ii
mimic
ii
databas
analyz
patient
admit
icu
beth
israel
deaco
medic
center
receiv
heparin
icu
stay
author
report
race
icu
type
gender
heparin
dose
age
sequenti
organ
failur
assess
score
associ
inappropri
aptt
use
complex
statist
analysi
final
propos
model
yet
formal
valid
predict
optim
dose
ufh
need
achiev
target
aptt
data
analysi
present
foundat
scientif
research
dissemin
appropri
statist
method
crucial
intens
care
medicin
frequent
involv
statist
review
earli
stage
review
process
filter
studi
suboptim
design
appli
inappropri
insuffici
report
statist
method
pool
et
al
use
two
exampl
name
diagnost
test
metaanalysi
interpret
illustr
common
statist
pitfal
note
even
statist
analys
appropri
correct
author
tendenc
overemphas
result
risk
translat
clinic
practic
treatment
benefit
risk
fulli
verifi
pool
colleagu
also
note
import
ethic
role
statist
review
play
minim
risk
clear
author
review
journal
editor
reader
share
respons
conflict
interest
none
